Gastrointestinal Carcinoid Tumors Research
Appendix Cancers Are Genetically Distinct from Other Gastrointestinal Cancers, Study ShowsPosted: September 12, 2018
The largest-ever study of DNA changes in appendix cancer shows that it is distinct from colorectal and other gastrointestinal cancers and suggests that specific mutations in appendix tumors may help predict whether they may be aggressive.
FDA Approves New Treatment for Certain Neuroendocrine TumorsPosted: February 8, 2018
People with cancerous neuroendocrine tumors (NETs) that affect the digestive tract now have a new treatment option. On January 29, FDA approved the targeted treatment lutetium Lu 177 dotatate (Lutathera®) for adult patients with advanced NETs that affect the pancreas or gastrointestinal tract.